Key result
Early identification of high-risk patients and prevention by mitigating risk factors remains the mainstay of management for cardiac surgery-associated acute kidney injury, as specific treatments lack strong evidence.
Early identification of high-risk patients and prevention by mitigating risk factors or avoiding renal insults remains the mainstay of management for cardiac surgery-associated acute kidney injury.
Answers are grounded in this paper and cite their sources.
Prioritizes prevention in cardiac surgery patients now; leaves open rigorous trials of targeted CSA-AKI therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eun‐Ho Lee (2016) conducted a review in Cardiac surgery-associated acute kidney injury (CSA-AKI). Early identification of high-risk patients and prevention by mitigating risk factors remains the mainstay of management for cardiac surgery-associated acute kidney injury, as specific treatments lack strong evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: